Receptor logo

Receptor

North America, New York, United States, New York

Description

Investing in the future of psychedelic medicine.

Investor Profile

Receptor has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (67%)
  • Pre Seed (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Life Science
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Receptor frequently co-invest with?

Ambria Capital
North America, NA - Puerto Rico, Puerto Rico, San Juan
Co-Investments: 1
Baird Inc
North America, Florida, United States, Sarasota
Co-Investments: 1
Negev Capital
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1
K2 & Associates
North America, Ontario, Canada, Toronto
Co-Investments: 1
What If Ventures
North America, Texas, United States, Frisco
Co-Investments: 1
Supernode
North America, British Columbia, Canada, Vancouver
Co-Investments: 1
JLS Fund
North America, New York, United States, New York
Co-Investments: 1
Iter Investments
North America, Florida, United States, Fort Lauderdale
Co-Investments: 1
The Conscious Fund
North America, Illinois, United States, Malta
Co-Investments: 1
Empath Ventures
North America, California, United States, Los Angeles
Co-Investments: 1

Which angels does Receptor often collaborate with?

BJ
Europe, Ile-de-France, France, Paris
Shared Deals: 1
VH
North America, New York, United States, New York
Shared Deals: 1
RH
Europe, Ile-de-France, France, Paris
Shared Deals: 1
JT
North America, Georgia, United States, Atlanta
Shared Deals: 1

What are some of recent deals done by Receptor?

MycroDose Therapeutics

San Diego, California, United States

Mycrodose Therapeutics is a pharmaceutical company specialized in the development of advanced drug delivery (ADD) systems

Health CarePharmaceutical
SeedSep 21, 2021
Mindstate Design Labs

Pittsburgh, Pennsylvania, United States

Mindstate Design Labs is a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics.

BiotechnologyHealth CareTherapeutics
Pre SeedAug 31, 2021
Amount Raised: $125,000
Psilera

Tampa, Florida, United States

Psilera is delivering next-generation psychedelics at home using a platform approach to derisk and scale the drug discovery & design process

BiotechnologyLife SciencePharmaceutical
SeedJul 1, 2021
Amount Raised: $2,500,000